Integral Diagnostics Limited
ITGDF
$2.06
$0.687450.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.75% | 7.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.75% | 7.83% | |||
| Cost of Revenue | -2.75% | 10.38% | |||
| Gross Profit | -2.75% | 2.52% | |||
| SG&A Expenses | -2.75% | 14.42% | |||
| Depreciation & Amortization | -2.75% | -0.40% | |||
| Other Operating Expenses | -2.75% | 351.47% | |||
| Total Operating Expenses | -2.75% | 9.35% | |||
| Operating Income | -2.75% | -6.95% | |||
| Income Before Tax | -2.79% | -95.46% | |||
| Income Tax Expenses | -2.75% | -69.15% | |||
| Earnings from Continuing Operations | 2.79% | -106.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.79% | -106.65% | |||
| EBIT | -2.75% | -6.95% | |||
| EBITDA | -2.75% | -3.81% | |||
| EPS Basic | 0.00% | -105.88% | |||
| Normalized Basic EPS | 0.00% | -97.67% | |||
| EPS Diluted | 0.00% | -106.85% | |||
| Normalized Diluted EPS | 0.00% | -97.62% | |||
| Average Basic Shares Outstanding | 0.00% | 5.89% | |||
| Average Diluted Shares Outstanding | 0.00% | 3.38% | |||
| Dividend Per Share | -3.57% | -22.94% | |||
| Payout Ratio | 0.00% | -19.78% | |||